IOVA
Iovance Biotherapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$8.79
+1.03%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 87.90x
- P/S forward
- 8.22x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 5.41x
- Price / sales
- 12.25x
- Price / cash flow
- -15.07x
Enterprise value
- Enterprise value
- $3.7B
- EV / sales
- 11.48x
- EV / EBITDA
- -14.19x
- EV / EBIT
- -12.38x
- Market cap
- $4.0B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026